Future Directions for the Management of Narcolepsy
Margaret Park, MD, and Russell Rosenberg, PhD, DABSM, provide clinical pearls and the future treatment landscape for the management of narcolepsy.v
Optimal Use of Narcolepsy Medications
Drs Margaret Park and Russell Rosenberg share considerations for the use of solriamfetol, lower-sodium oxybate, and pitolisant in narcolepsy for various patient populations.
Pitolisant Data and Its Place in Clinical Practice
Key opinion leaders in sleep medicine discuss the pitolisant studies and their experience using the drug in clinical practice.
Novel Treatment Options for the Management of Narcolepsy
Margaret Park, MD, and Russell Rosenberg, PhD, DABSM, provide insight on novel FDA-approved treatment options and their impact on the narcolepsy treatment landscape.
Managing Narcolepsy Treatment Adherence
Margaret Park, MD, leads the discussion on setting and managing patient expectations for treatment in narcolepsy.
Case 2: 22-Year-Old Man With Type 2 Narcolepsy
Expert sleep specialists review the case of a 22-year-old man who is diagnosed with excessive daytime sleepiness and type 2 narcolepsy and his challenges with treatment.
Challenges With the Use of Narcolepsy Medications
Drs Margaret Park and Russell Rosenberg illuminate challenges patients and providers face with narcolepsy medications, including potential substance abuse with scheduled substances.
Using Pharmacologic Interventions for Narcolepsy Management
Russell Rosenberg, PhD, DABSM, and Margaret Park, MD, review the optimal treatment selection of pharmacologic options for the management of patients with narcolepsy.
The Role of Nonpharmacologic Treatments in Narcolepsy
Expert sleep specialists explore the use of nonpharmacologic treatment approaches for the management of narcolepsy.
Challenges in the Diagnosis of Narcolepsy
Drs Margaret Park and Russell Rosenberg discuss challenges in the diagnosis of narcolepsy.
Approaching the Diagnosis of Narcolepsy
Key opinion leaders in sleep medicine discuss patient recognition of cataplexy symptoms in narcolepsy and their approach to narcolepsy diagnosis.
Case 1: 15-Year-Old Female With Excessive Daytime Sleepiness
Russell Rosenberg, PhD, DABSM, and Margaret Park, MD, review the case of a 15-year-old girl who presents with excessive daytime sleepiness and share clinical impressions on diagnosis and treatment.
Impact of Narcolepsy on Quality of Life
Experts in sleep medicine evaluate the impact of narcolepsy on a patient’s quality of life and expand on which symptoms appear to be most debilitating.
Margaret Park, MD, defines typical signs and symptoms of narcolepsy and differentiates between the 2 main types of disease.
2 Clarke Drive Cranbury, NJ 08512